V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005741 | 220002244 | 0 | 0 | Curative (C) | 2014-05-27 | 2014-06-09 | AML MyeChild 01 A Mitozantrone/Cytarabine + GO | Y | N | 220028859 | NOT MATCHED |
| 220005742 | 220002244 | 1.63 | 90 | Curative (C) | 2014-09-09 | 2014-09-13 | AML Interim Guidelines FLAG-Ida | N | N | 220028859 | FLAG + IDARUBICIN |
| 220005743 | 220002245 | 1.67 | 67 | Curative (C) | 2015-10-06 | 2015-10-06 | FLAG + Idarubicin | N | N | 220028863 | FLAG + IDARUBICIN |
| 220005744 | 220002245 | null | null | Curative (C) | 2017-02-20 | 2017-02-20 | AML MyeChild 01 A Mitozantrone/Cytarabine + GO | N | N | 220028863 | NOT MATCHED |
| 220005745 | 220016021 | null | 85 | Palliative (P) | 2014-12-16 | 2014-12-18 | AML Relapsed FLA - Idarubicin | N | N | 220028867 | NOT MATCHED |
| 220005746 | 220002246 | null | null | Curative (C) | 2015-02-02 | 2015-02-02 | AML MyeChild 01 A Mitozantrone/Cytarabine | N | N | 220028868 | NOT MATCHED |
| 220005747 | 220002246 | null | 0 | Curative (C) | 2014-05-15 | 2014-05-15 | Nilotinib | N | N | 220028868 | NILOTINIB |
| 220005748 | 220002246 | 0 | 0 | Curative (C) | 2017-12-04 | 2017-12-04 | Nilotinib | N | N | 220028868 | NILOTINIB |
| 220005749 | 220002247 | 1.77 | 106.6 | Curative (C) | 2016-02-13 | 2016-02-13 | FLAG + Idarubicin | N | N | 220028877 | FLAG + IDARUBICIN |
| 220005750 | 220002247 | null | 68.8 | Curative (C) | 2016-08-15 | 2016-08-23 | AML 19 TRIAL | 1 | N | 220028877 | AML19 TRIAL |
| 220005751 | 220002247 | 1.65 | 93.5 | Curative (C) | 2015-03-18 | 2015-03-18 | AML 19 TRIAL | Y | N | 220028877 | AML19 TRIAL |
| 220005752 | 220002247 | 0 | 0 | Palliative (P) | 2014-02-17 | 2014-05-21 | Nilotinib | N | N | 220028877 | NILOTINIB |
| 220005753 | 220002248 | null | null | Curative (C) | 2017-10-12 | 2017-11-02 | Nilotinib | 02 | N | 220028886 | NILOTINIB |
| 220005754 | 220002248 | 1.74 | 0 | Palliative (P) | 2013-03-21 | 2013-03-21 | Nilotinib | N | N | 220028886 | NILOTINIB |
| 220005755 | 220002249 | 1.68 | null | Curative (C) | 2017-01-14 | 2017-01-14 | AML 19 TRIAL | 2 | N | 220028890 | AML19 TRIAL |
| 220005756 | 220002249 | 1.73 | 106 | Curative (C) | 2016-12-22 | 2016-12-22 | FLAG + Idarubicin | N | N | 220028890 | FLAG + IDARUBICIN |
| 220005757 | 220002249 | 1.6 | null | Curative (C) | 2015-04-18 | 2015-07-11 | FLAG + Idarubicin | N | N | 220028890 | FLAG + IDARUBICIN |
| 220005758 | 220002249 | 0.81 | 48 | Curative (C) | 2015-11-08 | 2015-11-08 | CYTARABINE + Hydroxycarbamide | 2 | N | 220028890 | NOT MATCHED |
| 220005763 | 220020335 | 1.87 | 69.4 | Curative (C) | null | 2016-02-20 | AML 19 TRIAL | Y | N | 220028901 | AML19 TRIAL |
| 220005764 | 220020335 | 1.71 | 88 | Curative (C) | null | 2015-05-05 | AML 19 TRIAL | Y | N | 220028901 | AML19 TRIAL |
| 220005765 | 220020335 | 1.75 | 76.4 | Curative (C) | 2013-10-02 | 2013-10-04 | AML 19 TRIAL | 01 | N | 220028901 | AML19 TRIAL |
| 220005766 | 220002251 | 1.73 | 81.6 | Curative (C) | 2014-05-01 | 2014-05-01 | AML 19 TRIAL | 01 | N | 220028910 | AML19 TRIAL |
| 220005767 | 220002251 | null | 0 | Curative (C) | 2015-06-09 | 2015-06-09 | Nilotinib | N | N | 220028910 | NILOTINIB |
| 220005768 | 220002251 | 0 | null | Curative (C) | 2013-07-12 | 2013-07-12 | null | Y | N | 220028910 | NOT MATCHED |
| 220005769 | 220002251 | 1.47 | 101.8 | Curative (C) | null | 2016-03-28 | FLAG + Idarubicin | N | N | 220028910 | FLAG + IDARUBICIN |
| 220005770 | 220002252 | 1.58 | 61.6 | Curative (C) | 2015-03-18 | 2015-03-18 | AML 19 TRIAL | 1 | N | 220028923 | AML19 TRIAL |
| 220005771 | 220002252 | 1.73 | 95.2 | Curative (C) | null | 2016-04-06 | FLAG + Idarubicin | Y | N | 220028923 | FLAG + IDARUBICIN |
| 220005772 | 220002252 | null | 0 | Curative (C) | 2013-07-19 | 2013-07-26 | AML Interim Guidelines FLA | Y | N | 220028923 | NOT MATCHED |
| 220005773 | 220002252 | 1.75 | null | Curative (C) | 2014-08-20 | 2014-08-20 | null | N | N | 220028923 | NOT MATCHED |
| 220005774 | 220002253 | 1.74 | 104 | Curative (C) | 2017-05-21 | 2017-05-21 | AML Downs AIE | 02 | N | 220028933 | NOT MATCHED |
| 220005775 | 220002253 | 1.73 | 78.9 | Curative (C) | 2014-03-14 | 2014-05-08 | AML 19 TRIAL | 01 | N | 220028933 | AML19 TRIAL |
| 220005776 | 220002253 | null | 52.4 | Curative (C) | 2017-04-18 | 2017-04-21 | AML 19 TRIAL | Y | N | 220028933 | AML19 TRIAL |
| 220005777 | 220002253 | 1.85 | 86.1 | Curative (C) | null | 2014-08-19 | AML 19 TRIAL | Y | N | 220028933 | AML19 TRIAL |
| 220005778 | 220002253 | 0 | 83.5 | Palliative (P) | 2017-05-03 | 2017-05-03 | Nilotinib | 2 | Y | 220028933 | NILOTINIB |
| 220005779 | 220002254 | 0 | 12.8 | Curative (C) | 2013-07-03 | 2013-07-03 | AML MyeChild 01 A Mitozantrone/Cytarabine | Y | N | 220028943 | NOT MATCHED |
| 220005780 | 220002254 | null | 74 | Palliative (P) | 2017-06-21 | 2017-06-21 | APML Consolidation III ATRA, Idarubicin, Cytarabine | N | N | 220028943 | NOT MATCHED |
| 220005781 | 220002255 | null | 12.2 | Curative (C) | 2019-03-18 | 2019-03-19 | AML Interim Guidelines FLA -Ida | Y | N | 220028946 | NOT MATCHED |
| 220005782 | 220002256 | 0 | null | Disease modification (D) | 2013-08-04 | 2013-08-04 | Nilotinib | 02 | N | 220028948 | NILOTINIB |
| 220005783 | 220002256 | 1.7 | 0 | Not known (9) | 2016-02-20 | 2016-02-20 | Nilotinib | N | N | 220028948 | NILOTINIB |
| 220005784 | 220002256 | 1.85 | 75.4 | Curative (C) | 2015-12-20 | 2015-12-24 | AML 19 TRIAL | Y | N | 220028948 | AML19 TRIAL |
| 220005785 | 220002256 | 1.55 | 72 | Curative (C) | 2014-11-03 | 2014-11-03 | AML 19 TRIAL | 1 | N | 220028948 | AML19 TRIAL |
| 220005790 | 220020337 | 1.79 | 0 | Palliative (P) | 2016-04-08 | 2016-04-09 | Nilotinib | 02 | N | 220028960 | NILOTINIB |
| 220005791 | 220020337 | 1.85 | 118.9 | Curative (C) | null | 2014-05-27 | AML 19 TRIAL | N | N | 220028960 | AML19 TRIAL |
| 220005792 | 220021719 | 1.54 | 56 | Curative (C) | 2016-05-26 | 2016-05-26 | AML 19 TRIAL | Y | N | 220028965 | AML19 TRIAL |
| 220005793 | 220002258 | 1.74 | 98 | Palliative (P) | 2014-12-31 | 2014-12-31 | Nilotinib | 02 | N | 220028966 | NILOTINIB |
| 220005794 | 220002258 | 1.84 | null | Curative (C) | null | 2016-01-21 | FLAG + Idarubicin | N | N | 220028966 | FLAG + IDARUBICIN |
| 220005795 | 220002258 | 1.72 | 68.6 | Curative (C) | 2016-04-16 | 2016-04-16 | AML 19 TRIAL | N | N | 220028966 | AML19 TRIAL |
| 220005796 | 220002258 | 1.72 | 67.6 | Curative (C) | 2016-03-06 | 2016-03-07 | AML 19 TRIAL | 01 | N | 220028966 | AML19 TRIAL |
| 220005797 | 220002259 | 1.64 | 74.5 | Curative (C) | 2017-10-03 | 2017-10-03 | AML 19 TRIAL | N | N | 220028973 | AML19 TRIAL |
| 220005798 | 220002259 | 1.71 | 81.8 | Curative (C) | 2014-10-24 | 2014-10-24 | AML 19 TRIAL | 01 | null | 220028973 | AML19 TRIAL |